Pet Medtech
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- Undisclosed
Investors
- 3
About Pet Medtech
, trading as Pet Medtech, is an innovative pet drug developer, primarily engaged in the prevention, diagnosis, treatment, and healthcare of animal diseases, as well as veterinary drug production and distribution. The company has been awarded the title of National High-tech Enterprise. Pet Medtech focuses on innovative pet drugs and high-end formulation platforms, combining imitation and innovation to address the current shortage of veterinary drugs and medications in the pet treatment field. It is committed to building a one-stop innovative technology service platform for pet health, with products covering the prevention, diagnosis, treatment, and health maintenance of pet diseases. The company’s revenue is generated from the sale of pet medicines and pet disease treatment services. It will continue to integrate AI to deeply develop its R&D pipeline so as to bring original Chinese-developed pet drugs to the global market as soon as possible.
Who invested in Pet Medtech
3 investors across 2 rounds
See all investors in Pet Medtech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pet Medtech
Who invested in Pet Medtech?
Pet Medtech has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pet Medtech raised?
Pet Medtech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pet Medtech last raise money?
Pet Medtech's most recent round on record is a Series A, in Jul 2026.
What does Pet Medtech do?
, trading as Pet Medtech, is an innovative pet drug developer, primarily engaged in the prevention, diagnosis, treatment, and healthcare of animal diseases, as well as veterinary drug production and distribution.
Where is Pet Medtech headquartered?
Pet Medtech is headquartered in Nanjing, China.
Which VCs invest in companies like Pet Medtech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Pet Medtech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pet Medtech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.